Stock Events

Stock Events

UroGen Pharma (URGN) Q2 2024 Earnings

13MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-1.14

-0.99

-0.83

-0.68

Details

Expected EPS

-0.86658

Actual EPS

-0.97

Surprise EPS

-0.1

Surprise Percent

+11.93%

Description

UroGen Pharma (URGN) has reported earnings of -0.97 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.